https://www.cgtlive.com/view/cber-interactive-cgt-site-tours-improve-communication-share-best-practicesCBER To Conduct Interactive CGT Site Tours to Improve Communication, Share Best Practices
July 17, 2024 — The FDA has announced a Cellular and Gene Therapies Interactive Site Tours Program (the Interactive Site Tours Program) to improve communication and share best practices between industry and the regulatory agency.
The program will see regulatory managers from the Center for Biologics Evaluation and Research (CBER) touring biotechnology manufacturing facilities developing cellular and gene therapy products.
“With this program, CBER intends to enhance review efficiency and quality by providing CBER staff with a better understanding of the biotechnology manufacturing industry and its operations,” the Federal Register notice that the program was announced in stated.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.68 |
Change
-0.165(8.97%) |
Mkt cap ! $2.140B | |||
| Open | High | Low | Value | Volume |
| $1.81 | $1.83 | $1.67 | $14.80M | 8.635M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $1.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 2000 | 1 |
View Market Depth
| Last trade - 16.20pm 02/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |